Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gasbarrini

Showing results (221-230 of 2,258) with videos related to

Pageof 226
Sort By:
American Journal of Physical Anthropology|April 8, 2014
Palaeodiet reconstruction in a woman with probable celiac disease: a stable isotope analysis of bone remains from the archaeological site of Cosa (Italy)Gabriele Scorrano, Mauro Brilli, Cristina Martínez-Labarga, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 11, 2000
Prevalence of factor V Leiden and the G20210A prothrombin-gene mutation in inflammatory bowel diseaseA Papa, V De Stefano, A Gasbarrini, et al.
Alimentary Pharmacology & Therapeutics|December 1, 2004
Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trialE C Nista, M Candelli, F Cremonini, et al.
Journal of Hepatology|September 1, 1992
Bed-rest-induced hypernatriuresis in cirrhotic patients without ascites: does it contribute to maintain 'compensation'?F Trevisani, M Bernardi, A Gasbarrini, et al.
Journal of Hepatology|January 1, 1995
Hemodynamic and renal effects of ascites apheresis, concentration and reinfusion in advanced cirrhosisM Bernardi, A Gasbarrini, F Trevisani, et al.
Helicobacter|September 16, 2015
Extragastric Diseases and Helicobacter pyloriFrancesco Franceschi, Antonio Gasbarrini, Stergios A Polyzos, et al.
Expert Opinion on Investigational Drugs|June 6, 2018
The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn's diseaseLoris R Lopetuso, Marco Napoli, Gianenrico Rizzatti, et al.
Helicobacter|August 24, 2006
Extragastric manifestations of Helicobacter pylori infection--other Helicobacter speciesJay V Solnick, Francesco Franceschi, D Roccarina, et al.
Gut|June 1, 1979
Cyclic AMP and cyclic GMP levels in human colonic mucosa before and during chenodeoxycholic acid therapyG R Corazza, R Ciccarelli, F Caciagli, et al.
European Review for Medical and Pharmacological Sciences|August 1, 2006
Acute paraplegia by epidural abscess: full neurological recovery following surgical decompressionF De Iure, A Gasbarrini, S Paderni, et al.
Pageof 226

Showing results (221-230 of 2,258) with videos related to

Sort By:
Pageof 226
American Journal of Physical Anthropology|April 8, 2014
Palaeodiet reconstruction in a woman with probable celiac disease: a stable isotope analysis of bone remains from the archaeological site of Cosa (Italy)Gabriele Scorrano, Mauro Brilli, Cristina Martínez-Labarga, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 11, 2000
Prevalence of factor V Leiden and the G20210A prothrombin-gene mutation in inflammatory bowel diseaseA Papa, V De Stefano, A Gasbarrini, et al.
Alimentary Pharmacology & Therapeutics|December 1, 2004
Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trialE C Nista, M Candelli, F Cremonini, et al.
Journal of Hepatology|September 1, 1992
Bed-rest-induced hypernatriuresis in cirrhotic patients without ascites: does it contribute to maintain 'compensation'?F Trevisani, M Bernardi, A Gasbarrini, et al.
Journal of Hepatology|January 1, 1995
Hemodynamic and renal effects of ascites apheresis, concentration and reinfusion in advanced cirrhosisM Bernardi, A Gasbarrini, F Trevisani, et al.
Helicobacter|September 16, 2015
Extragastric Diseases and Helicobacter pyloriFrancesco Franceschi, Antonio Gasbarrini, Stergios A Polyzos, et al.
Expert Opinion on Investigational Drugs|June 6, 2018
The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn's diseaseLoris R Lopetuso, Marco Napoli, Gianenrico Rizzatti, et al.
Helicobacter|August 24, 2006
Extragastric manifestations of Helicobacter pylori infection--other Helicobacter speciesJay V Solnick, Francesco Franceschi, D Roccarina, et al.
Gut|June 1, 1979
Cyclic AMP and cyclic GMP levels in human colonic mucosa before and during chenodeoxycholic acid therapyG R Corazza, R Ciccarelli, F Caciagli, et al.
European Review for Medical and Pharmacological Sciences|August 1, 2006
Acute paraplegia by epidural abscess: full neurological recovery following surgical decompressionF De Iure, A Gasbarrini, S Paderni, et al.
Pageof 226